Overall, 1,710 patients had sporadic breast cancer; the BRCA1/2 double mutation frequency was 1.35% (23/1710), and the BRCA1/2 and PALB2 triple mutation frequency was 0.94% (16/1710; Table 7; Figure 4). This evidence concerns the gene BRCA1 and breast carcinoma.